Cargando…

Opportunities and challenges for the inclusion of patient preferences in the medical product life cycle: a systematic review

BACKGROUND: The inclusion of patient preferences (PP) in the medical product life cycle is a topic of growing interest to stakeholders such as academics, Health Technology Assessment (HTA) bodies, reimbursement agencies, industry, patients, physicians and regulators. This review aimed to understand...

Descripción completa

Detalles Bibliográficos
Autores principales:	Janssens, Rosanne, Huys, Isabelle, van Overbeeke, Eline, Whichello, Chiara, Harding, Sarah, Kübler, Jürgen, Juhaeri, Juhaeri, Ciaglia, Antonio, Simoens, Steven, Stevens, Hilde, Smith, Meredith, Levitan, Bennett, Cleemput, Irina, de Bekker-Grob, Esther, Veldwijk, Jorien
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6778383/ https://www.ncbi.nlm.nih.gov/pubmed/31585538 http://dx.doi.org/10.1186/s12911-019-0875-z

Ejemplares similares

Factors and Situations Affecting the Value of Patient Preference Studies: Semi-Structured Interviews in Europe and the US
por: Whichello, Chiara, et al.
Publicado: (2019)

Patient Preferences in the Medical Product Life Cycle: What do Stakeholders Think? Semi-Structured Qualitative Interviews in Europe and the USA
por: Janssens, Rosanne, et al.
Publicado: (2019)

Design, Conduct, and Use of Patient Preference Studies in the Medical Product Life Cycle: A Multi-Method Study
por: van Overbeeke, Eline, et al.
Publicado: (2019)

Appraising patient preference methods for decision-making in the medical product lifecycle: an empirical comparison
por: Whichello, Chiara, et al.
Publicado: (2020)

Patient Preferences in Rare Diseases: A Qualitative Study in Neuromuscular Disorders to Inform a Quantitative Preference Study
por: Jimenez-Moreno, A. Cecilia, et al.
Publicado: (2021)

Correction to: Patient Preferences in Rare Diseases: A Qualitative Study in Neuromuscular Disorders to Inform a Quantitative Preference Study
por: Jimenez-Moreno, A. Cecilia, et al.
Publicado: (2021)

Patient Involvement in the Lifecycle of Medicines According to Belgian Stakeholders: The Gap Between Theory and Practice
por: Janssens, Rosanne, et al.
Publicado: (2018)

Methodological Priorities for Patient Preferences Research: Stakeholder Input to the PREFER Public–Private Project
por: Smith, Ian P., et al.
Publicado: (2021)

A study protocol for quantifying patient preferences in neuromuscular disorders: a case study of the IMI PREFER Project
por: Jimenez-Moreno, Aura Cecilia, et al.
Publicado: (2020)

Use of Patient Preferences in Health Technology Assessment: Perspectives of Canadian, Belgian and German HTA Representatives
por: van Overbeeke, Eline, et al.
Publicado: (2020)

Benefit–risk evaluation: the past, present and future
por: Juhaeri, Juhaeri
Publicado: (2019)

How can patient preferences be used and communicated in the regulatory evaluation of medicinal products? Findings and recommendations from IMI PREFER and call to action
por: Janssens, Rosanne, et al.
Publicado: (2023)

Discrete choice experiment versus swing-weighting: A head-to-head comparison of diabetic patient preferences for glucose-monitoring devices
por: Whichello, Chiara, et al.
Publicado: (2023)

The Impact of Video-Based Educational Materials with Voiceovers on Preferences for Glucose Monitoring Technology in Patients with Diabetes: A Randomised Study
por: Smith, Ian P., et al.
Publicado: (2023)

Patient Preferences to Assess Value IN Gene Therapies: Protocol Development for the PAVING Study in Hemophilia
por: van Overbeeke, Eline, et al.
Publicado: (2021)

Opportunities and Challenges of Web-Based and Remotely Administered Surveys for Patient Preference Studies in a Vulnerable Population
por: Oliveri, Serena, et al.
Publicado: (2021)

Patients as research partners in preference studies: learnings from IMI-PREFER
por: Smith, Meredith Y., et al.
Publicado: (2023)

Does It Matter How You Ask? Assessing the Impact of Failure or Effectiveness Framing on Preferences for Antibiotic Treatments in a Discrete Choice Experiment
por: Smith, Ian P, et al.
Publicado: (2022)

Diabetes patient preferences for glucose-monitoring technologies: results from a discrete choice experiment in Poland and the Netherlands
por: Smith, Ian P, et al.
Publicado: (2023)

Predicting the risk of end-stage renal disease in the population-based setting: a retrospective case-control study
por: Johnson, Eric S, et al.
Publicado: (2011)

Hypothesis-free signal detection in healthcare databases: finding its value for pharmacovigilance
por: Bate, Andrew, et al.
Publicado: (2019)

Patient Centricity in Patient Preference Studies: The Patient Perspective
por: van Overbeeke, Eline, et al.
Publicado: (2020)

Patient preferences for gene therapy in haemophilia: Results from the PAVING threshold technique survey
por: van Overbeeke, Eline, et al.
Publicado: (2021)

Patient Preferences for Lung Cancer Treatment: A Qualitative Study Protocol Among Advanced Lung Cancer Patients
por: Durosini, Ilaria, et al.
Publicado: (2021)

Structured benefit–risk evaluation for medicinal products: review of quantitative benefit–risk assessment findings in the literature
por: Kürzinger, Marie-Laure, et al.
Publicado: (2020)

What matters most to patients with multiple myeloma? A Pan-European patient preference study
por: Janssens, Rosanne, et al.
Publicado: (2022)

Performance assessment of different machine learning approaches in predicting diabetic ketoacidosis in adults with type 1 diabetes using electronic health records data
por: Li, Lin, et al.
Publicado: (2021)

Public Preferences for Introducing a COVID-19 Certificate: A Discrete Choice Experiment in the Netherlands
por: Veldwijk, J., et al.
Publicado: (2023)

Web-Based Signal Detection Using Medical Forums Data in France: Comparative Analysis
por: Kürzinger, Marie-Laure, et al.
Publicado: (2018)

Patient Preferences for Multiple Myeloma Treatments: A Multinational Qualitative Study
por: Janssens, Rosanne, et al.
Publicado: (2021)

Balancing benefits and risks in lung cancer therapies: patient preferences for lung cancer treatment alternatives
por: Oliveri, Serena, et al.
Publicado: (2023)

Patient Preferences for Lung Cancer Treatments: A Study Protocol for a Preference Survey Using Discrete Choice Experiment and Swing Weighting
por: Monzani, Dario, et al.
Publicado: (2021)

Risk of interstitial lung disease in patients treated for atrial fibrillation with dronedarone versus other antiarrhythmics
por: Tave, Arlene, et al.
Publicado: (2021)

The Effect of Including an Opt-Out Option in Discrete Choice Experiments
por: Veldwijk, Jorien, et al.
Publicado: (2014)

COVID-19 Contact Tracing Apps: Predicted Uptake in the Netherlands Based on a Discrete Choice Experiment
por: Jonker, Marcel, et al.
Publicado: (2020)

Taking the Shortcut: Simplifying Heuristics in Discrete Choice Experiments
por: Veldwijk, Jorien, et al.
Publicado: (2023)

Improving Patient Involvement in the Lifecycle of Medicines: Insights From the EUPATI BE Survey
por: Grine, Lynda, et al.
Publicado: (2020)

Patient perspectives regarding gene therapy in haemophilia: Interviews from the PAVING study
por: van Overbeeke, Eline, et al.
Publicado: (2020)

Public perceptions of myocardial infarction: Do illness perceptions predict preferences for health check results
por: Grauman, Åsa, et al.
Publicado: (2022)

What Factors Influence Non-Participation Most in Colorectal Cancer Screening? A Discrete Choice Experiment
por: de Bekker-Grob, Esther W., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_22u210ruata5a7e551ufc7f78i